Rainbow BioSciences Impressed by Nano3d Biosciences’ Award-Winning Track Record

Rainbow Coral’s division, Rainbow BioSciences said that it was impressed with the award-winning track record of Nano3D Biosciences, a developer of advanced nanoparticle cell-growth technology. Rainbow BioSciences has recently announced that it has started the due diligence analysis for a possible joint venture or acquisition of Nano3D Biosciences.

Nano3D Biosciences received the $250,000 Pre-Seed Commercialization Award from the Texas Emerging Technology Fund in June 2010 for the development of a novel device that grows cells magnetically, allowing the growth of three-dimensional tissue utilizing a proprietary proportion of nanoparticle-based reagents. The company is entitled to get a total fund of $1 million via the Texas Emerging Technology Fund.

Nano3D Biosciences had been awarded the first Goradia Innovation Prize in September 2010 at the Gulf Coast Innovation Conference & Showcase. Consequently, the company received $10,000 from the Houston Technology Center. The possibility for a long-term success, the capability to create jobs within the region, the reliability of the business plan and the innovation’s market potential were the selection criteria for the award.

Nano3D Biosciences has been well accepted by the pharmaceutical and medical research community. The UT Health Science Center, Baylor College of Medicine, Methodist Hospital and MD Anderson Cancer Center are some of the current customers of the company.

The Chief Executive Officer at Rainbow Coral, Patrick Brown stated that these awards and recognition by the Texas Medical Center is a testament to the value of Nano3D Biosciences and strengthens Rainbow BioSciences’ decision to proceed with its plans for Nano3D Biosciences.

Source: http://www.rainbowbiosciences.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). Rainbow BioSciences Impressed by Nano3d Biosciences’ Award-Winning Track Record. AZoNano. Retrieved on April 14, 2024 from https://www.azonano.com/news.aspx?newsID=23994.

  • MLA

    Chai, Cameron. "Rainbow BioSciences Impressed by Nano3d Biosciences’ Award-Winning Track Record". AZoNano. 14 April 2024. <https://www.azonano.com/news.aspx?newsID=23994>.

  • Chicago

    Chai, Cameron. "Rainbow BioSciences Impressed by Nano3d Biosciences’ Award-Winning Track Record". AZoNano. https://www.azonano.com/news.aspx?newsID=23994. (accessed April 14, 2024).

  • Harvard

    Chai, Cameron. 2019. Rainbow BioSciences Impressed by Nano3d Biosciences’ Award-Winning Track Record. AZoNano, viewed 14 April 2024, https://www.azonano.com/news.aspx?newsID=23994.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.